1-Benzyl-4-oxoazepane hydrochloride, 97.0%, 250mg

2-Trifluoromethyl-quinazolin-4-ol, 95.0%, 500mg

((E)-1-But-1-enyl)-pyrrolidine, 95.0%, 5g

Butyl trimethyl ammonium bis(trifluoromethylsulfonyl)imide min 99% 25g

7-Methoxy-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-c]pyridine, 95%, 100mg

5-Fluoro-6-methylnicotinonitrile, 95%, 250mg

1-(Piperidin-1-yl)hexadecan-1-one, 98%, 250mg

2,3-Dibromo-1,1,1,4,4,4-hexafluorobutane, 5g

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

6,7-Dichloro-1H-indole, 97%, 1g

1-{[(butan-2-yl)amino]methyl}naphthalen-2-ol, 95.0%, 1g

Methyl 6-chloro-5-hydroxynicotinate, 95.0%, 5g

2,8-Diamino-6-fluoro-5-methyl-3,4-dihydronaphthalen-1(2H)-one hydrochloride, 98%, 25mg